• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

narcolepsy

Close up of horse legs and hooves running on sand track
Biotech

Takeda, Alkermes lift lid on narcolepsy rivals as race heats up

Takeda and Alkermes took data from their OX2R-selective agonists to Singapore as the race to get a new class of narcolepsy drug to market heats up.
James Waldron Sep 8, 2025 6:47am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Chasing Takeda, Alkermes reports phase 2 narcolepsy win

Jul 21, 2025 8:40am
Arrows hitting targets

Takeda narcolepsy blockbuster hopeful secures double ph. 3 wins

Jul 14, 2025 5:51am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Alkermes impresses in full-throttle narcolepsy race with Takeda

Jun 4, 2024 9:01am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Phase 2b narcolepsy win powers Takeda toward pivotal trials

Feb 9, 2024 6:02am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Jazz halts sleep disorder med trial over 'visual disturbances'

Nov 29, 2023 10:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings